Compare RR & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RR | ZVRA |
|---|---|---|
| Founded | 2016 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 583.6M | 472.9M |
| IPO Year | 2023 | 2015 |
| Metric | RR | ZVRA |
|---|---|---|
| Price | $2.31 | $8.87 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 7 |
| Target Price | $6.00 | ★ $21.71 |
| AVG Volume (30 Days) | ★ 11.1M | 553.2K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 34.27 |
| EPS | N/A | ★ 1.16 |
| Revenue | $5,045,000.00 | ★ $23,612,000.00 |
| Revenue This Year | $75.68 | $333.64 |
| Revenue Next Year | $78.28 | $44.19 |
| P/E Ratio | ★ N/A | $7.73 |
| Revenue Growth | ★ 18.99 | N/A |
| 52 Week Low | $1.41 | $6.19 |
| 52 Week High | $7.43 | $13.16 |
| Indicator | RR | ZVRA |
|---|---|---|
| Relative Strength Index (RSI) | 36.02 | 50.36 |
| Support Level | $1.83 | $8.61 |
| Resistance Level | $2.33 | $9.10 |
| Average True Range (ATR) | 0.17 | 0.36 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 5.07 | 52.44 |
Richtech Robotics Inc is a robotics and artificial intelligence (AI) technology company focused on developing embodied AI systems that aims to improve the efficiency and productivity of businesses. The company trains proprietary artificial intelligence models on in-house data to operate robotic systems in the real world. It designs, engineers, manufactures, and deploys next generation embodied AI systems to serve a wide range of industries, including food service, retail, industrial manufacturing, automotive, healthcare, and hospitality. The company's offerings include Commercial Robotic Products, Industrial Robotic Products and Data Services. The company generated the majority of its revenue through product revenue (i.e. outright hardware sales).
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.